Target intelligence / Profile preview

Bacterial-type ribosome (apicoplast)

Molecular classification
Ribosome, Other (Organelle protein synthesis complex)
01

Overview

The **Bacterial-type ribosome (apicoplast)** is a unique ribosomal complex found in the apicoplast, an essential non-photosynthetic plastid organelle of apicomplexan parasites such as *Plasmodium* (malaria) and *Toxoplasma*. Structurally, it most closely resembles the bacterial 70S ribosome, being composed of large (50S) and small (30S) subunits, and retains bacterial-like rRNA and protein components, albeit with significant reduction and divergence compared to canonical bacterial ribosomes. The apicoplast ribosome mediates the translation of its own small genome as well as nucleus-encoded apicoplast-targeted proteins and is indispensable for parasite viability. Its bacterial ancestry and structural differences from host cytoplasmic ribosomes make it a validated and selective target for anti-apicomplexan drugs such as macrolide and lincosamide antibiotics. Many such drugs inhibit translation by binding specific sites in the ribosomal RNA or proteins, leading to parasite death—often characterized by a "delayed death" phenotype due to the essential maintenance functions of the apicoplast. Therapeutic exploitation is challenged by potential cross-reactivity with host mitochondria and slow parasiticidal activity of some inhibitors[1][2][4][5][7][8][9].

Other names
Apicoplast ribosomeBacterial ribosome (apicoplast)Organelle ribosome (apicoplast)70S ribosome (apicoplast)Plasmodium apicoplast ribosome
02

Mechanism of action

Inhibition of protein synthesis by binding the ribosome (large or small subunits), blocking peptide elongation or initiation[2][4][5][8].

03

Biological functions

Protein synthesisTranslation of organellar genesOther (Organelle maintenance, metabolic pathway support)
04

Disease associations

Infection (as a validated drug target in malaria and other apicomplexan diseases)
05

Safety considerations

Specificity/challenges in targeting parasite ribosomes without affecting human mitochondriaDelayed therapeutic effect with certain drugs (e.g., "delayed death" phenotype in malaria)[6]
06

Interacting drugs

Azithromycin

4 more in the full profile.

Beyond the preview

Go deeper on Bacterial-type ribosome (apicoplast).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial-type ribosome (apicoplast).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call